Statement | Frequency (%) | p-value* | ||||
---|---|---|---|---|---|---|
Strongly unsatisfied | Unsatisfied | Neutral | Satisfied | Strongly satisfied | ||
Are you satisfied with the medication surveillance? | 27 (2.4) | 61 (5.5) | 323 (29.0) | 488 (43.9) | 213 (19.2) | < 0.001 |
Physicians | 22 (4.4) | 49 (9.8) | 151 (30.2) | 210 (42.0) | 68 (13.6) | |
Pharmacists | 5 (0.8) | 12 (2.0) | 172 (28.1) | 278 (45.4) | 145 (23.7) | |
Do you think the medication surveillance has improved the following? | ||||||
Prevention of adverse drug reactions | 21 (1.9) | 103 (9.3) | 278 (25.0) | 468 (42.1) | 241 (21.7) | < 0.001 |
Physicians | 19 (3.8) | 70 (14.1) | 133 (26.7) | 197 (39.6) | 79 (15.9) | |
Pharmacists | 2 (0.3) | 33 (5.4) | 145 (23.7) | 271 (44.2) | 162 (26.4) | |
Decrease in therapeutic duplication | 17 (1.5) | 65 (5.8) | 165 (14.8) | 440 (39.5) | 426 (38.3) | < 0.001 |
Physicians | 13 (2.6) | 34 (6.8) | 86 (17.2) | 204 (40.8) | 163 (32.6) | |
Pharmacists | 4 (0.7) | 31 (5.1) | 79 (12.9) | 236 (38.5) | 263 (42.9) | |
Decrease in drug overuse | 27 (2.4) | 112 (10.1) | 269 (24.2) | 432 (38.8) | 272 (24.5) | < 0.001 |
Physicians | 23 (4.6) | 52 (10.4) | 115 (23.0) | 197 (39.5) | 112 (22.4) | |
Pharmacists | 4 (0.7) | 60 (9.8) | 154 (25.1) | 235 (38.3) | 160 (26.1) |